Primary record
(1R,2R)-N-[(2S)-1-[4-(5-bromanyl-2-oxidanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenyl-cyclopropane-1-carboxamide;2,2,2-tris(fluoranyl)ethanoic acid
- 库存
- 5,362 克
- 纯度
- 99.6 %
- CAS
- 1246303-14-9
化合物标识与属性
- CAS
- 1246303-14-9
- PubChem CID
- 44573131
- SMILES
- C[C@@H](CN1CCC(CC1)N2C3=C(C=C(C=C3)Br)NC2=O)NC(=O)[C@@H]4C[C@H]4C5=CC=CC=C5
- Canonical SMILES
- C[C@@H](CN1CCC(n2c(=O)[nH]c3cc(Br)ccc32)CC1)NC(=O)[C@@H]1C[C@H]1c1ccccc1
名称与同义词
- VU0359595
- 1246303-14-9
- CHEMBL524182
- ML270
- orb1704970
- SCHEMBL10277051
- SCHEMBL29607257
- BDBM87119
- AOB1035
- cid_53470193
- JSVNNLRZCJAYTQ-ORYQWCPZSA-N
- DTXSID801382176
- GLXC-02716
- WZB30314
- BDBM50257541
- EX-A11064
- ZINC40953486
- AKOS027320660
- NCGC00386841-03
- NCGC00386841-04
- VU-0359595
- CID-53361951
- DA-59075
- MS-29232
- HY-101293
- CS-0021093
- J3.162.442H
- VU0359595-1
- G14167
- Cyclopropanecarboxamide, N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-, (1R,2R)-
- VU0359595 (2)
- VU0359595, >=97% (HPLC)
- VU 0359595;VU0359595
- (1R,2R)-N-((S)-1-(4-(5-Bromo-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-phenylcyclopropanecarboxamide
- (1R,2R)-N-[(2S)-1-[4-(5-Bromo-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide
- (1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide
- (1R,2R)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide
- (1r,2r)-N-([s]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1h-benzo(d)imidazol-1-yl]piperidin-1-yl} propan-2-yl)-2-phenylcyclopropanecarboxamide
- (1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide (Inh_VU0359595)
- (1R,2R)-N-[(1S)-2-[4-(5-bromo-2-keto-3H-benzimidazol-1-yl)piperidino]-1-methyl-ethyl]-2-phenyl-cyclopropanecarboxamide;2,2,2-trifluoroacetic acid
- (1R,2R)-N-[(2S)-1-[4-(5-bromanyl-2-oxidanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenyl-cyclopropane-1-carboxamide;2,2,2-tris(fluoranyl)ethanoic acid
- (1R,2R)-N-[(2S)-1-[4-(5-bromo-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide
- (1R,2R)-N-[(2S)-1-[4-(5-bromo-2-oxo-3H-1,3-benzodiazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide
- (1R,2R)-N-[(2S)-1-[4-(5-bromo-2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]propan-2-yl]-2-phenyl-1-cyclopropanecarboxamide;2,2,2-trifluoroacetic acid
- (1R,2R)-N-[(2S)-1-[4-(5-bromo-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide;2,2,2-trifluoroacetic acid
- (1R,2R)-N-[(S)-2-[4-(5-Bromo-2-oxo-2,3-dihydro-1H-benzoimidazole-1-yl)piperidine-1-yl]-1-methylethyl]-2-phenylcyclopropane-1-carboxamide
- racemic trans-N-((S)-1-(4-(5-bromo-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-phenylcyclopropanecarboxamide